Company
Product List
Offer to buy
Offer to sell
Sign In
Join
Help
Languages
English
繁體中文
簡體中文
Shijiazhuang Pharm-chem technology Co.,Ltd
Home
Company Profile
Products
Video
Inquiry
Contact Us
Recommended Results
Animal Tablets
Category :
Biotech->Biochemistry->veterinary medicine
View Larger Picture
View Larger Picture
View Larger Picture
Product Specification
Model No:
Animal Tablets
Country
CN
Product Detail
Albendazole 300 mg. bolus
(Item No.: TB002)
Composition:
Contains per bolus.:
Albendazole......................................................300 mg
Carrier ad.......................................................... 4 g
Description:
Albendazole is a synthetic anthelmintic which belongs to the group of benzimidazole-derivatives with activity against a broad range of worms and at a higher dosage level also against adult stages of liver fluke.
Indications:
Prophylaxis and treatment of worminfections in cattle, calves, sheep and goats like:
Gastrointestinal worms: Bunostomum, Cooperia, Chabertia, Haemonchus,
Nematodirus, Oesophagostomum, Ostertagia, Strongyloides and Trichostrongylus spp.
Lung worms: Dictyocaulus viviparus and D. filaria.
Tapeworms: Monieza spp.
Liver-fluke: adult Fasciola hepatica.
Dosage:
For oral administration.
Calves and cattle: 1 bolus per 60 kg. body weight.
For liver-fluke: 1 bolus per 35 kg. body weight.
Sheep and goats: 1 bolus per 35 kg. body weight.
For liver-fluke: 1 bolus per 30 kg. body weight.
Contra indications:
Administration in the first 45 days of gestation.
Side effects:
Hypersensitivity reactions.
Withdrawal times:
For meat: 12 days.
For milk: 4 days.
Warning:Keep out of reach of children.
Levamisole 150mg bolus
(Item No.: TB004)
Composition:
Contains per bolus.:
Albendazole......................................................150 mg Carriere ad 6g
Albendazole......................................................600 mg Carriere ad 6g
Albendazole......................................................1000 mg Carriere ad 6g
Pharmacology
Levamisole is an imidazothiazole that acts by interfering with parasite nerve transmission causing muscular paralysis. It stimulates the parasympathetic and sympathetic ganglia in susceptible worms. At higher levels, levamisole interferes with nematode carbohydrate metabolism by blocking fumarate reduction and succinate oxidation. The net effect is a paralyzing effect on the worm which is then expelled alive. Levamisole's effects are considered to be nicotine-like in action.
Pharmacokinetics
Levamisole is absorbed from the gut after oral dosing and through the skin after dermal application, although bioavailabilities are variable. It is reportedly distributed throughout the body. Levamisole is primarily metabolized with less than 6% excreted unchanged in the urine. Plasma elimination half-lives have been determined for several veterinary species: Cattle 4-6 hours; Dogs 1.8-4 hours; and Swine 3.5-6.8 hours. Metabolites are excreted in both the urine (primarily) and feces.
Indications
Levamisole is indicated for the treatment of many nematodes in cattle, sheep & goats, swine, poultry. In sheep and cattle, levamisole has relatively good activity against abomasal nematodes, small intestinal nematodes (not particularly good against Strongyloides spp.), large intestinal nematodes (not Trichuris spp.), and lungworms. Adult forms of species that are usually covered by levamisole, include: Haemonchus spp., Trichostrongylus spp., Osteragia spp., Cooperia spp., Nematodirus spp., Bunostomum spp., Oesophagostomum spp., Chabertia spp., and Dictyocaulus vivapurus. Levamisole is less effective against the immature forms of these parasites and is generally ineffective in cattle (but not sheep) against arrested larval forms.
In swine, levamisole is indicated for the treatment of Ascaris suum, Oesophagostomum spp., Strongyloides, Stephanurus, and Metastrongylus.
Levamisole has been used in dogs as a microfilaricide to treat Dirofilaria immitis infection.
Contraindications/PrecautionsLevamisole is contraindicated in lactating animals. It should be used cautiously, if at all, in animals that are severely debilitated, or have significant renal or hepatic impairment. Use cautiously or, preferably, delay use in cattle that are stressed due to vaccination, dehorning or castration. There is no information regarding the safety of this drug in pregnant animals. Although levamisole is considered relatively safe to use in large animals that are pregnant, use only if the potential benefits outweigh the risks.
Adverse Effects/Warnings
Adverse effects that may be seen in cattle can include muzzle-foaming or hypersalivation, excitement or trembling, lip-licking and head shaking. These effects are generally noted with higher than recommended doses or if levamisole is used concomitantly with organophosphates. Symptoms generally subside within 2 hours. When injecting into cattle, swelling may occur at the injection site. This will usually abate in 7-14 days, but may be objectionable in animals that are close to slaughter.
In sheep, levamisole may cause a transient excitability in some animals after dosing. In goats, levamisole may cause depression, hyperesthesia and salivation.
In swine, levamisole may cause salivation or muzzle foaming. Swine infected with lungworms may develop coughing or vomiting.
Adverse effects that may be seen in dogs include GI disturbances (usually vomiting, diarrhea), neurotoxicity (panting, shaking, agitation or other behavioral changes), agranulocytosis, dyspnea, pulmonary edema, immune-mediated skin eruptions (erythroedema, erythema multiforme, toxic epidermal necrolysis) and lethargy.
Adverse effects seen in cats include hypersalivation, excitement, mydriasis and vomiting.
Dosage and Administration
For oral administration. The general dosage is 5-7.5 mg Levamisole per kg bodyweight.
For more specific details relating to each bolus, see table below.
Bolus Dosage
150mg 1 bolus per 25kg body weight
600mg 1 bolus per 100kg body weight
1000mg 1 bolus per 150kg body weight
Withdrawal PeriodCattle (meat & offal): 5 daysSheep (meat & offal): 5 daysNot to be used in animals producing milk for human consumption.
Storage
The recommended maximum storage temperature is 30℃.Warning:Keep out of reach of children.
Tetramisole 300 mg
(Item No.: TB007)
Composition:
Each bolus contains:
Tetramisole Hcl…………………………………………300 mg
Carriere ad ………………………………………………….5g
Description:
Tetramisole is indicated for the treatment like Haemonchus sp, Ostertagia spp, Trichostrongylus spp, Nematodirus sp, Bunostomum spp, Oesophagostomum spp, Cooperia sp, Dictyocaulus sp, Ascaris suum, Strongyloides ransomi; Metastrongylus spp, Oesophagostomum sp, Ascaridia spp and Capillaria. Within 24 hours therapeutic blood levels are obtained. Tetramisole is mainly excreted in urine.
Indication:
Tetramisole is intended for the treatment of different worm infection in cattle,swine and poultry; Dictiocaulosis, Haemonchosis, Bunostomosis, Oesophagostomiasis, Nematodirus, Cooperiosis, Strongyloidiasis, Ascaridosis, Oesophagostomiasis, Strongyloides, Trichocephalus, Metastrongilosis, Ascaridosis, Capillariasis, Heteracidosis and Singamoz.
Dosage and Administration:
For oral administration:
Cattle & sheep; 1 bolus per 30 kg body weight
Swine; 1 bolus per 25 kg body weight
Poultry; 1 bolus per 10-20 kg body weight
Side Effects:
No undesirable effects are to be expected when the prescribed dosage regimen is followed.
Contra-indication:
- Administration to infections.
- Administration to last third period of gestation.
- Administration to animal with an impaired liver function.
- Administration to animal with an impaired renal function.
- Concurrent administration of Pyrantel, Morantel or organ-phosphates.
Withdrawal Period:
For meat; 7 days
For milk; 2 days
Packing:
100 boluses (300 mg)
Storage condition:
Store in a cool, dry and dark place, below 30°C
Warning: keep out of the children
More Products from this Supplier
Albendazole oral suspension 10%
Toltrazuril Oral solution 2.5%
Benzalkonium Bromide Solution (10%)
[ Back Products Catalog ]
Commerce Member:
Please log in your ID and password, we will later fill in relating info.
ID:
Password:
Remember my ID on this computer
Complete this form below to send out your enquiries.
All enquiries will be automatically sent to the company you want to develop.
Subject
Content
(Don't input Company Name, E-Mail, Phone Number, Fax Number, and URL)
Company Profile:
*
Company Name
*
E-mail
*
Country
Please Select Your Country
United States
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaidjan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
Former Czechoslovakia
Former USSR
France
France (European Territory)
French Guyana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Great Britain
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion (French)
Romania
Russian Federation
Rwanda
S. Georgia & S. Sandwich Isls.
Saint Helena
Saint Kitts & Nevis Anguilla
Saint Lucia
Saint Pierre and Miquelon
Saint Tome (Sao Tome) and Principe
Saint Vincent & Grenadines
Samoa
San Marino
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Tajikistan
Taiwan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City State
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (USA)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
*
Contact Person
URL
*
Phone
-
-
Fax
-
-
*
Postal code
*
City
*
Street Address
*
Business Nature
Distributor
Exporter
Importer
Manufacturer
Whole Sale
Retailer
Reseller
Retrofitter
User
Others, please specify:
*
Security Code
Enter the security code.
Site Map l
Privacy Policy l
Company Profile l
Corporate Proposal l
Contact Us l
Help l
Advertise With Us l
World Trade Link
.